Skip to main content
. 2011 Oct 29;378(9802):1560–1571. doi: 10.1016/S0140-6736(11)60937-9

Table 3.

Summary data for secondary outcome measures at follow-ups of 4 months and 12 months

All participants
Low–risk participants
Medium–risk participants
High–risk participants
Intervention group (n=568) Control group (n=283) Point estimate (95% CI) p value Intervention group (n=148) Control group (n=73) Point estimate (95% CI) p value Intervention group (n=263) Control group (n=131) Point estimate (95% CI) p value Intervention group (n=157) Control group (n=79) Point estimate (95% CI) p value
Back pain intensity
4 months, mean change (SD) 3·2 (2·5) 2·6(2·4) 0·55* (0·23 to 0·86) 0·0005 1·7 (2·2) 1·5(2·1) 0·28* (−0·29 to 0·84) 0·3182 3·5 (2·6) 2·8(2·1) 0·58* (0·06 to 1·10) 0·0200 4·2 (2·3) 3·4(2·9) 0·73* (0·04 to 1·42) 0·0316
12 months, mean change (SD) 3·0 (2·8) 2·8(2·6) 0·11* (−0·21 to 0·43) 0·5002 1·7 (2·3) 1·7(2·4) 0·10* (−0·51 to 0·70) 0·7461 3·3 (2·6) 3·0(2·8) 0·16* (−0·44 to 0·76) 0·5802 3·7 (2·7) 3·6(3·2) −0·01* (−0·72 to 0·70) 0·9755
STarT Back risk group
4 months .. .. 2·09 (1·40 to 3·12) 0·0003 .. .. 1·16 (0·36 to 3·67) 0·8021 .. .. 1·70 (0·95 to 3·03) 0·0678 .. .. 3·14 (1·63 to 6·06) 0·0006
Low risk 439 (77%) 186 (66%) .. .. 134 (91%) 65 (89%) .. .. 201 (76%) 89 (68%) .. .. 104 (66%) 32 (41%) .. ..
Medium risk 103 (18%) 70(25%) .. .. 12 (8%) 7(10%) .. .. 55 (21%) 36(27%) .. .. 36 (23%) 27(34%) .. ..
High risk 26 (5%) 27(10%) .. .. 2 (1%) 1(1%) .. .. 7 (3%) 6(5%) .. .. 17 (11%) 20(25%) .. ..
12 months .. .. 1·51 (1·01 to 2·25) 0·0405 .. .. 0·91 (0·31 to 2·65) 0·8562 .. .. 1·51 (0·85 to 2·66) 0·1525 .. .. 1·62 (0·82 to 3·23) 0·1566
Low risk 430 (76%) 195 (69%) .. .. 131 (89%) 65 (89%) .. .. 204 (78%) 94 (72%) .. .. 95 (61%) 36 (46%) .. ..
Medium risk 111 (20%) 71 (25%) .. .. 17 (11%) 7(10%) .. .. 56 (21%) 35(27%) .. .. 38 (24%) 29(37%) .. ..
High risk 27 (5%) 17(6%) .. .. 0 1(1%) .. .. 3 (1%) 2(2%) .. .. 24 (15%) 14(18%) .. ..
Global change
4 months .. .. 1·55 (1·16 to 2·07) 0·0032 .. .. 1·45 (0·80 to 2·60) 0·2153 .. .. 1·57 (1·04 to 2·36) 0·0304 .. .. 1·70 (0·98 to 2·96) 0·0595
Much better 252 (44%) 99(35%) .. .. 70 (47%) 28(38%) .. .. 125 (48%) 50(38%) .. .. 57 (36%) 21(27%) .. ..
Better 151 (27%) 82(29%) .. .. 38 (26%) 23(32%) .. .. 70 (27%) 40(31%) .. .. 43 (27%) 19(24%) .. ..
Not better 165 (29%) 102(36%) .. .. 40 (27%) 22(30%) .. .. 68 (26%) 41(31%) .. .. 57 (36%) 39(49%) .. ..
12 months .. .. 1·23 (0·95 to 1·60) 0·1104 .. .. 0·80 (0·41 to 1·54) 0·4812 .. .. 1·54 (0·99 to 2·39) 0·0520 .. .. 1·26 (0·72 to 2·21) 0·4072
Much better 229 (40%) 99(35%) .. .. 57 (39%) 32(44%) .. .. 116 (44%) 46(35%) .. .. 56 (36%) 21(27%) .. ..
Better 121 (21%) 63(22%) .. .. 36 (24%) 17(23%) .. .. 59 (22%) 31(24%) .. .. 26 (17%) 15(19%) .. ..
Not better 218 (38%) 121(43%) .. .. 55 (37%) 24(33%) .. .. 88 (33%) 54(41%) .. .. 75 (48%) 43(54%) .. ..
PCS–catastrophising
4 months, mean change (SD) 6·4 (10·8) 3·9(10·4) 2·35* (0·91 to 3·79) 0·0010 2·6 (7·3) 1·3(8·0) 1·10* (−0·82 to 3·02) 0·2590 5·9 (10·1) 3·6(10·1) 1·88* (−0·09 to 3·84) 0·0531 10·8 (12·1) 6·9(13·3) 3·91* (0·41 to 7·41) 0·0242
12 months, mean change (SD) 6·1 (10·6) 4·4(11·4) 1·69* (0·37 to 3·01) 0·0113 3·2 (8·6) 1·6(7·7) 1·47* (−0·60 to 3·54) 0·1516 5·7 (9·0) 3·6(10·5) 1·74* (−0·11 to 3·60) 0·0630 9·4 (12·1) 8·1(12·7) 1·35* (−1·70 to 4·40) 0·3816
TSK–fear avoidance
4 months, mean change (SD) 5·5 (7·0) 3·2(6·0) 2·52* (1·61 to 3·43) <0·0001 3·5 (7·1) 2·8(7·3) 0·86* (−1·01 to 2·73) 0·3540 5·2 (7·9) 2·8(5·7) 2·72* (1·45 to 3·98) <0·0001 7·9 (8·0) 4·3(6·0) 3·70* (1·70 to 5·70) 0·0003
12 months, mean change (SD) 5·2 (7·3) 3·3(10·3) 2·18* (0·73 to 3·63) 0·0013 3·5 (7·2) 2·4(9·3) 1·22* (−1·26 to 3·70) 0·3030 4·9 (7·6) 3·2(8·2) 2·14* (0·23 to 4·04) 0·0181 7·3 (7·7) 4·3(7·2) 3·12* (1·18 to 5·06) 0·0016
HADS, anxiety subscale
4 months, mean change (SD) 1·7 (3·6) 1·2(4·0) 0·63* (0·08 to 1·18) 0·0208 0·6 (3·3) 0·9(3·5) −0·17* (−0·97 to 0·62) 0·6666 1·7 (3·8) 0·8(3·7) 1·10* (0·33 to 1·86) 0·0039 2·8 (4·3) 2·2(4·5) 0·56* (−0·57 to 1·69) 0·3155
12 months, mean change (SD) 1·3 (3·9) 1·0(4·4) 0·45* (−0·10 to 1·01) 0·1035 0·5 (3·2) 0·8(4·0) −0·13* (−1·22 to 0·96) 0·8023 1·3 (4·2) 0·6(4·2) 0·88* (0·08 to 1·68) 0·0283 2·1 (4·5) 1·7(5·0) 0·28* (−1·14 to 1·71) 0·6783
HADS, depression subscale
4 months, mean change (SD) 1·7 (3·7) 1·1(3·3) 0·71* (0·26 to 1·15) 0·0018 0·3 (3·2) 0·2(3·3) 0·09* (−0·69 to 0·88) 0·8086 1·7 (3·6) 1·2(3·5) 0·79* (0·13 to 1·45) 0·0193 3·0 (4·3) 1·9(3·8) 1·13* (0·16 to 2·09) 0·0223
12 months, mean change (SD) 1·4 (4·1) 0·9(4·0) 0·62* (0·07 to 1·17) 0·0227 0·2 (3·3) 0·2(3·5) −0·03* (−0·92 to 0·86) 0·9494 1·3 (3·7) 1·0(3·8) 0·63* (−0·10 to 1·36) 0·0863 2·7 (4·7) 1·5(4·5) 1·21* (0·02 to 2·40) 0·0413
SF12, physical component
4 months, mean change (SD) −7·5 (13·0) −5·2(13·3) −2·83* (−4·62 to −1·05) 0·0010 −3·2 (9·6) −1·8(9·7) −1·50* (−3·89 to 0·89) 0·2137 −9·1 (11·7) −6·4(10·7) −3·27* (−5·51 to −1·03) 0·0037 −8·9 (15·1) −6·4(15·8) −3·13* (−7·50 to 1·23) 0·1215
12 months, mean change (SD) −7·5 (11·3) −5·2(10·9) −2·93* (−4·31 to −1·56) <0·0001 −4·0 (9·7) −2·4(10·1) −1·70* (−4·25 to 0·85) 0·1825 −8·8 (11·5) −5·7(11·7) −3·74* (−6·02 to −1·46) 0·0012 −8·6 (12·2) −6·8(13·1) −2·46* (−5·90 to 0·97) 0·1464
SF12, mental component
4 months, mean change (SD) −2·1 (11·3) −2·1(11·0) −0·16* (−1·63 to 1·32) 0·8327 0·5 (12·4) −1·0(10·2) 0·96* (−1·68 to 3·60) 0·4640 −1·5 (10·4) −1·1(12·0) −0·80* (−2·92 to 1·31) 0·4497 −5·5 (12·5) −4·8(14·3) −0·27* (−3·98 to 3·45) 0·8811
12 months, mean change (SD) −1·7 (13·0) −1·2(13·4) −0·69* (−2·39 to 1·01) 0·4050 1·3 (10·7) −0·4(9·9) 1·18* (−1·12 to 3·49) 0·3124 −1·2 (12·3) −0·1(12·7) −1·53* (−3·62 to 0·55) 0·1468 −5·5 (13·8) −3·6(13·8) −1·31* (−5·04 to 2·43) 0·4682
Work loss
Days off work, mean (SD) 4·4 (21·2) 12·2(35·1) 2·76§ (2·52 to 3·01) <0·0001 0·4 (1·2) 3·0(11·9) 7·06§ (4·28 to 11·6) <0·0001 4·1 (15·8) 18·4(47·2) 5·17§ (4·52 to 5·92) <0·0001 9·9 (35·4) 10·6(18·2) 1·46§ (1·24 to 1·72) <0·0001
Satisfaction with care .. .. 1·98 (1·45 to 2·70) <0·0001 .. .. 1·24 (0·68 to 2·25) 0·4784 .. .. 2·15 (1·35 to 3·40) 0·0013 .. .. 3·18 (1·68 to 6·00) 0·0005
Very satisfied 166/416 (40%) 46/197(23%) .. .. 30/106 (28%) 14/56(25%) .. .. 87/197 (44%) 22/91(24%) .. .. 49/113 (43%) 10/50(20%) .. ..
Quite satisfied' 139/416 (33%) 81/197(41%) .. .. 33/106 (31%) 21/56(38%) .. .. 63/197 (32%) 39/91(43%) .. .. 43/113 (38%) 21/50(42%) .. ..
Not satisfied 111/416 (27%) 70/197(36%) .. .. 43/106 (41%) 21/56(38%) .. .. 47/197 (24%) 30/91(33%) .. .. 21/113 (19%) 19/50(38%) .. ..

Data are number (%), unless otherwise indicated. PCS=Pain Catastrophizing Scale. TSK=Tampa Scale of Kinesiophobia. HADS=Hospital Anxiety and Depression Scale. SF12=Short Form 12. RMDQ=Roland and Morris Disability Questionnaire.

*

Mean difference—ie, mean for the intervention group minus mean for the control group (by use of linear regression adjusted for age, sex, baseline score, baseline RMDQ, and duration of back pain).

Odds ratio represents the proportional odds in terms of ordered response categories for the intervention group relative to the control group (by use of ordinal logistic regression adjusted for age, sex, baseline RMDQ, and duration of back pain).

Analysis of time off work (days) is based on a total subsample of 298 of 567 responders who reported being currently employed at 12 months follow-up, and relates to leave due to low back pain during the period between baseline and follow-up at 12 months.

§

Incidence rate ratio for the extra work days lost in the control group relative to the intervention group (by use of Poisson regression adjusted for age, sex, baseline RMDQ, and duration of back pain).

Analysis was based on 613 responders to the question about satisfaction with care at 4 months follow-up: 416 in the intervention group and 197 in the control group.